237 related articles for article (PubMed ID: 27793447)
21. The argument for conservative, delayed surgery in the management of prostatic rhabdomyosarcoma.
Lobe TE; Wiener E; Andrassy RJ; Bagwell CE; Hays D; Crist WM; Webber B; Breneman JC; Reed MM; Tefft MC; Heyn R
J Pediatr Surg; 1996 Aug; 31(8):1084-7. PubMed ID: 8863239
[TBL] [Abstract][Full Text] [Related]
22. Combined modality therapy with conservation of organ function in childhood genitourinary rhabdomyosarcoma.
Middleton AW; Elman AJ; Stewart JR; O'Brien RT; Johnson DG
Urology; 1981 Jul; 18(1):42-6. PubMed ID: 7257037
[TBL] [Abstract][Full Text] [Related]
23. Urogenital rhabdomyosarcoma in children: is a conservative surgical approach justified?
Heij HA; Vos A; de Kraker J; Voute PA
J Urol; 1993 Jul; 150(1):165-8. PubMed ID: 8510241
[TBL] [Abstract][Full Text] [Related]
24. Organ-preserving management of rhabdomyosarcoma of the prostate and bladder in children.
Silván AM; Gordillo MJ; Lopez AM; Cuevas GP; Gutiérrez JA; Iriondo JM; Cantón JA; Caro AM; Quesada ML; Arceaga MA; Vallés MC
Med Pediatr Oncol; 1997 Dec; 29(6):573-5. PubMed ID: 9324347
[TBL] [Abstract][Full Text] [Related]
25. Neoadjuvant interstitial high-dose-rate (HDR) brachytherapy combined with systemic chemotherapy in patients with breast cancer.
Roddiger SJ; Kolotas C; Filipowicz I; Kurek R; Kuner RP; Martin T; Baltas D; Rogge B; Kontova M; Hoffmann G; Pollow B; Zamboglou N
Strahlenther Onkol; 2006 Jan; 182(1):22-9. PubMed ID: 16404517
[TBL] [Abstract][Full Text] [Related]
26. [Brachytherapy in the treatment of vesicoprostatic rhabdomyosarcomas in children].
Haie-Meder C; Breton-Callu C; Oberlin O; Martelli H; Audry G; Valayer J; Habrand JL; Terrier-Lacombe MJ; Gerbaulet A
Cancer Radiother; 2000 Nov; 4 Suppl 1():145s-149s. PubMed ID: 11194954
[TBL] [Abstract][Full Text] [Related]
27. Bladder and prostatic tumors in the intergroup Rhabdomyosarcoma study (IRS-I): results of therapy.
Hays DM; Raney RB; Lawrence W; Soule EH; Gehan EA; Tefft M
Cancer; 1982 Oct; 50(8):1472-82. PubMed ID: 6749275
[TBL] [Abstract][Full Text] [Related]
28. Sexual function in teenagers after multimodal treatment of pelvic rhabdomyosarcoma: A preliminary report.
Macedo A; Ferreira PV; Barroso U; Demarchi GT; Garrone G; Liguori R; Caran E; Ortiz V
J Pediatr Urol; 2010 Dec; 6(6):605-8. PubMed ID: 20619744
[TBL] [Abstract][Full Text] [Related]
29. Urogenital rhabdomyosarcoma in Nigerian children.
Familusi JB; Nkposong EO; Attah EB
Trop Geogr Med; 1977 Mar; 29(1):29-34. PubMed ID: 883007
[TBL] [Abstract][Full Text] [Related]
30. [The role of brachytherapy in the therapeutic strategy of vesico-prostatic rhabdomyosarcoma in children].
Haie-Meder C; Flamant F; Revillon Y; Valayer J; Gruner M; Martelli H; Habrand JL; Terrier-Lacombe MJ; Gerbaulet A
Ann Urol (Paris); 1994; 28(6-7):302-5. PubMed ID: 7893115
[TBL] [Abstract][Full Text] [Related]
31. Conservative management of a perianal rhabdomyosarcoma in a 2-year old child by Papillon's technique.
Demoor-Goldschmidt C; Dumoucel S; Haie-Meder C; Corradini N; Mahé MA; Supiot S
Radiat Oncol; 2015 May; 10():108. PubMed ID: 25927819
[TBL] [Abstract][Full Text] [Related]
32. AMORE treatment as salvage treatment in children and young adults with relapsed head-neck rhabdomyosarcoma.
Vaarwerk B; Hol MLF; Schoot RA; Breunis WB; de Win MML; Westerveld H; Fajardo RD; Saeed P; van den Brekel MW; Pieters BR; Strackee SD; Smeele LE; Merks JHM
Radiother Oncol; 2019 Feb; 131():21-26. PubMed ID: 30773183
[TBL] [Abstract][Full Text] [Related]
33. Local control with reduced-dose radiotherapy for low-risk rhabdomyosarcoma: a report from the Children's Oncology Group D9602 study.
Breneman J; Meza J; Donaldson SS; Raney RB; Wolden S; Michalski J; Laurie F; Rodeberg DA; Meyer W; Walterhouse D; Hawkins DS
Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):720-6. PubMed ID: 22104356
[TBL] [Abstract][Full Text] [Related]
34. The role of surgery in the management of pediatric pelvic rhabdomyosarcoma.
Lerner SP; Hayani A; O'Hollaren P; Winkel C; Ohori M; Harberg FJ; Roth DR; Gonzales ET
J Urol; 1995 Aug; 154(2 Pt 1):540-5. PubMed ID: 7609132
[TBL] [Abstract][Full Text] [Related]
35. Treatment of urogenital tract rhabdomyosarcoma in infants and children.
Tank ES; Fellmann SL; Wheeler ES; Weaver DK; Lapides J
J Urol; 1972 Feb; 107(2):324-8. PubMed ID: 5061467
[No Abstract] [Full Text] [Related]
36. Innovation in the management of soft tissue sarcomas in infants and young children: high-dose-rate brachytherapy.
Nag S; Martínez-Monge R; Ruymann F; Jamil A; Bauer C
J Clin Oncol; 1997 Sep; 15(9):3075-84. PubMed ID: 9294470
[TBL] [Abstract][Full Text] [Related]
37. Outcome for children with group III rhabdomyosarcoma treated with or without radiotherapy.
Viswanathan AN; Grier HE; Litman HJ; Perez-Atayde A; Tarbell NJ; Neuberg D; Shamberger RC; Marcus KJ
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1208-14. PubMed ID: 15001265
[TBL] [Abstract][Full Text] [Related]
38. Salvage brachytherapy for recurrent prostate cancer after definitive radiation therapy: A comparison of low-dose-rate and high-dose-rate brachytherapy and the importance of prostate-specific antigen doubling time.
Kollmeier MA; McBride S; Taggar A; Anderson E; Lin M; Pei X; Weiji S; Voros L; Cohen G; Yamada Y; Zelefsky MJ
Brachytherapy; 2017; 16(6):1091-1098. PubMed ID: 28838648
[TBL] [Abstract][Full Text] [Related]
39. Modelling second malignancy risks from low dose rate and high dose rate brachytherapy as monotherapy for localised prostate cancer.
Murray L; Mason J; Henry AM; Hoskin P; Siebert FA; Venselaar J; Bownes P;
Radiother Oncol; 2016 Aug; 120(2):293-9. PubMed ID: 27370205
[TBL] [Abstract][Full Text] [Related]
40. Continent urinary reconstruction in rhabdomyosarcoma: a new approach.
Freitas RG; Nobre YT; Macedo A; Demarchi GT; Ortiz V; Srougi M
J Pediatr Surg; 2004 Sep; 39(9):1333-7. PubMed ID: 15359386
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
